These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8325311)

  • 1. The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents--lack of relationship to pretreatment streptokinase resistance.
    Gemmill JD; Hogg KJ; Douglas JT; Dunn FG; Lowe GD; Rae AP; Hillis WS
    Eur Heart J; 1993 Jun; 14(6):819-25. PubMed ID: 8325311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of influence of pretreatment antistreptokinase antibody on efficacy in a multicenter patency comparison of intravenous streptokinase and anistreplase in acute myocardial infarction.
    Fears R; Hearn J; Standring R; Anderson JL; Marder VJ
    Am Heart J; 1992 Aug; 124(2):305-14. PubMed ID: 1636574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
    Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
    Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Streptokinase-induced hypotension has no detrimental effect on patients with thrombolytic treatment for acute myocardial infarction. A substudy of the Romanian Study for Accelerated Streptokinase in Acute Myocardial Infarction (ASK-ROMANIA).
    Tatu-Chiţoiu G; Teodorescu C; Dan M; Guran M; Căpraru P; Istrăţescu O; Tatu-Chiţoiu A; Bumbu A; Chioncel V; Arvanitopol S; Dorobanţu M
    Rom J Intern Med; 2004; 42(3):557-73. PubMed ID: 16366130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- and long-term comparative study of anistreplase versus streptokinase in acute myocardial infarction.
    Silber H; Hausmann MJ; Katz A; Gilutz H; Zucker N; Ovsyshcher I
    Angiology; 1992 Jul; 43(7):572-7. PubMed ID: 1626735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.
    Fears R; Ferres H; Glasgow E; Standring R; Hogg KJ; Gemmill JD; Burns JM; Rae AP; Dunn FG; Hillis WS
    Br Heart J; 1992 Aug; 68(2):167-70. PubMed ID: 1389731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypotension in acute myocardial infarction patients given streptokinase.
    Lateef F; Anantharaman V
    Singapore Med J; 2000 Apr; 41(4):172-6. PubMed ID: 11063182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptokinase-induced transient aggravation of myocardial injury.
    Arstall MA; Stewart S; Haste MA; Horowitz JD
    Int J Cardiol; 1995 Jun; 50(2):107-16. PubMed ID: 7591321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood viscosity during thrombolytic therapy with anistreplase in acute myocardial infarction.
    Hoffmann JJ; Bonnier JJ; Melman PG; Bartholomeus I
    Am J Cardiol; 1993 Jan; 71(1):14-8. PubMed ID: 8420229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase.
    Salvioni A; Marenzi GC; Agostoni P; Grazi S; Guazzi MD
    Eur Heart J; 1994 May; 15(5):654-9. PubMed ID: 8056006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter patency trial of intravenous anistreplase compared with streptokinase in acute myocardial infarction. The TEAM-2 Study Investigators.
    Anderson JL; Sorensen SG; Moreno FL; Hackworthy RA; Browne KF; Dale HT; Leya F; Dangoisse V; Eckerson HW; Marder VJ
    Circulation; 1991 Jan; 83(1):126-40. PubMed ID: 1984877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of results of intravenous infusion of anistreplase versus streptokinase in acute myocardial infarction.
    Vogt P; Monnier P; Schaller MD; Goy JJ; Beuret P; Essinger A; Bachmann F; Hauert J; Perret C; Sigwart U
    Am J Cardiol; 1993 Feb; 71(4):274-80. PubMed ID: 8427167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of fibrinogen breakdown related to coronary patency and bleeding complications in patients with thrombolysis in acute myocardial infarction--results from the PRIMI trial.
    Ostermann H; Schmitz-Huebner U; Windeler J; Bär F; Meyer J; van de Loo J
    Eur Heart J; 1992 Sep; 13(9):1225-32. PubMed ID: 1396833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the possibility of accelerating thrombolytic therapy in the acute phase of myocardial infarction: efficacy of and tolerance to the infusion of 1.5 million units of streptokinase in 30 minutes].
    Mazzotta G; Cavazzana G; Camerini A; Lupi G; Vecchio C
    G Ital Cardiol; 1989 Jan; 19(1):53-8. PubMed ID: 2744315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Influence of the coronary anatomical substrate.
    Salvioni A; Perego GB; Marenzi G; Lauri G; Giraldi F; Grazi S; Guazzi MD
    Eur Heart J; 1996 Feb; 17(2):230-6. PubMed ID: 8732376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood viscosity and platelet function in thrombolytic therapy of acute myocardial infarction.
    Hoffmann JJ
    Eur Heart J; 1990 Aug; 11 Suppl F():29-35. PubMed ID: 2121489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-dosing antibody levels and efficacy of thrombolytic drugs containing streptokinase.
    Gemmill JD; Hogg KJ; Dunn FG; Rae AP; Hillis WS
    Br Heart J; 1994 Sep; 72(3):222-5. PubMed ID: 7946770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic versus fibrinogenolytic activity of rt-PA and streptokinase in patients with acute myocardial infarction.
    Prisco D; Bonechi F; Scarti L; Tramontana M; Abbate R; Gensini GF
    Angiology; 1990 Aug; 41(8):616-20. PubMed ID: 2117862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern strategies for treatment of acute myocardial infarction: significance of haemostaseological and rheological findings.
    Pindur G; Sen C; Wenzel E; Jung F; Ozbek C; Schwerdt H; Schieffer H; Bette L; Miyashita C
    Adv Exp Med Biol; 1990; 281():389-94. PubMed ID: 2129376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of hypotension during streptokinase infusion in suspected acute myocardial infarction, and its relation to prognosis and metoprolol therapy.
    Herlitz J; Hartford M; Aune S; Karlsson T
    Am J Cardiol; 1993 May; 71(12):1021-4. PubMed ID: 8475862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.